Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jan;32(1):181-3.
doi: 10.2337/dc08-1406. Epub 2008 Oct 3.

Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance

Affiliations

Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance

Zsuzsanna Putz et al. Diabetes Care. 2009 Jan.

Abstract

Objective: To evaluate neural dysfunction in subjects with impaired glucose tolerance (IGT).

Research design and methods: For this study, 46 subjects with IGT and 45 healthy volunteers underwent detailed neurological assessment. Cardiovascular autonomic function was assessed by standard cardiovascular reflex tests, and heart rate variability was characterized by the triangle index. Sensory nerve function was assessed using Neurometer (for current perception threshold) and Medoc devices. Peak plantar pressure was measured by dynamic pedobarography, and symptoms were graded using the neuropathy total symptom score.

Results: Subjects with IGT had significantly greater abnormalities detected by four of five cardiovascular reflex tests and greater heart rate variability characterized by the triangle index. They had a higher frequency of both hyperesthesia and hypoesthesia as detected by current perception threshold testing at 5 Hz, as well as increased heat detection thresholds.

Conclusions: This study provides evidence that subclinical neural dysfunction is present in subjects with IGT and can be detected noninvasively. Cardiovascular autonomic neuropathy may contribute to increased cardiovascular risk in IGT subjects.

PubMed Disclaimer

References

    1. Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu-Tirgoviste C, Witte DR, Fuller JH, EURODIAB Prospective Complications Study Group: Vascular risk factors and diabetic neuropathy. N Engl J Med 352:341–350, 2005 - PubMed
    1. de Neeling JN, Beks PJ, Bertelsmann FW, Heine RJ, Bouter LM: Peripheral somatic nerve function in relation to glucose tolerance in an elderly Caucasian population: the Hoorn study. Diabet Med 13:960–966, 1996 - PubMed
    1. Eriksson KF, Nilsson H, Lindgärde F, Osterlin S, Dahlin LB, Lilja B, Rosén I, Sundkvist G: Diabetes mellitus but not impaired glucose tolerance is associated with dysfunction in peripheral nerves. Diabet Med 11:279–285, 1994 - PubMed
    1. Bastyr EJ 3rd, Price KL, Bril V; the MBBQ Study Group: Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Clin Ther 27:1278–1294, 2005 - PubMed
    1. Pitei DL, Watkins PJ, Stevens MJ, Edmonds ME: The value of the Neurometer in assessing diabetic neuropathy by measurement of the current perception threshold. Diabet Med 11:872–876, 1994 - PubMed

Publication types

MeSH terms